{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "immune responses",
      "immunity",
      "infection",
      "respiratory viruses"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33896688",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.tim.2021.03.016",
      "S0966-842X(21)00092-5"
    ],
    "Journal": {
      "ISSN": "1878-4380",
      "JournalIssue": {
        "Volume": "29",
        "Issue": "7",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "Trends in microbiology",
      "ISOAbbreviation": "Trends Microbiol"
    },
    "ArticleTitle": "Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.",
    "Pagination": {
      "StartPage": "648",
      "EndPage": "662",
      "MedlinePgn": "648-662"
    },
    "Abstract": {
      "AbstractText": [
        "Even in nonpandemic times, respiratory viruses account for a vast global burden of disease. They remain a major cause of illness and death and they pose a perpetual threat of breaking out into epidemics and pandemics. Many of these respiratory viruses infect repeatedly and appear to induce only narrow transient immunity, but the situation varies from one virus to another. In the absence of effective specific treatments, understanding the role of immunity in protection, disease, and resolution is of paramount importance. These problems have been brought into sharp focus by the coronavirus disease 2019 (COVID-19) pandemic. Here, we summarise what is now known about adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and draw comparisons with immunity to other respiratory viruses, focusing on the longevity of protective responses."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: m.siggins@imperial.ac.uk."
          }
        ],
        "LastName": "Siggins",
        "ForeName": "Matthew K",
        "Initials": "MK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Heart and Lung Institute, Imperial College London, London, UK."
          }
        ],
        "LastName": "Thwaites",
        "ForeName": "Ryan S",
        "Initials": "RS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: p.openshaw@imperial.ac.uk."
          }
        ],
        "LastName": "Openshaw",
        "ForeName": "Peter J M",
        "Initials": "PJM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MR/V028448/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trends Microbiol",
    "NlmUniqueID": "9310916",
    "ISSNLinking": "0966-842X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Trends Microbiol. 2021 Sep;29(9):862",
      "PMID": "34229912"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adaptive Immunity"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Viruses"
    }
  ],
  "CoiStatement": "Declaration of Interests There are no interests to declare."
}